U.S. markets close in 1 hour 28 minutes
  • S&P 500

    4,198.59
    +76.12 (+1.85%)
     
  • Dow 30

    33,233.26
    +458.85 (+1.40%)
     
  • Nasdaq

    12,810.11
    +316.18 (+2.53%)
     
  • Russell 2000

    1,964.58
    +51.69 (+2.70%)
     
  • Crude Oil

    92.23
    +1.73 (+1.91%)
     
  • Gold

    1,808.40
    -3.90 (-0.22%)
     
  • Silver

    20.66
    +0.17 (+0.84%)
     
  • EUR/USD

    1.0308
    +0.0091 (+0.89%)
     
  • 10-Yr Bond

    2.7920
    -0.0050 (-0.18%)
     
  • GBP/USD

    1.2231
    +0.0155 (+1.28%)
     
  • USD/JPY

    133.0070
    -2.1090 (-1.56%)
     
  • BTC-USD

    23,788.56
    +749.38 (+3.25%)
     
  • CMC Crypto 200

    560.22
    +29.00 (+5.46%)
     
  • FTSE 100

    7,507.11
    +18.96 (+0.25%)
     
  • Nikkei 225

    27,819.33
    -180.63 (-0.65%)
     

Electromed, Inc. to Participate in the Canaccord Genuity 42nd Annual Growth Conference

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

NEW PRAGUE, Minn., July 19, 2022--(BUSINESS WIRE)--Electromed, Inc. ("Electromed" or the "Company") (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that Kathleen Skarvan, President and Chief Executive Officer, and Michelle Wirtz, Interim Chief Financial Officer, are scheduled to participate in the Canaccord Genuity 42nd Annual Growth Conference on August 8-11, 2022. Management will be available for investor one-on-ones on Wednesday, August 10, 2022.

About Electromed, Inc.

Electromed, Inc. manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest® Airway Clearance System, to patients with compromised pulmonary function. The Company is headquartered in New Prague, Minnesota and was founded in 1992. Further information about the Company can be found at www.smartvest.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220719006102/en/

Contacts

Michelle Wirtz, Interim Chief Financial Officer
(952) 758-9299
investorrelations@electromed.com

Mike Cavanaugh, Investor Relations
ICR Westwicke
(617) 877-9641
mike.cavanaugh@westwicke.com